Glasgow Alcoholic Hepatitis Score
The Glasgow Alcoholic Hepatitis Score predicts short‑term mortality and identifies which patients with severe alcoholic hepatitis benefit from corticosteroids 1.
Indicações de Uso
Used in adults with suspected or confirmed alcoholic hepatitis to stratify short‑term mortality risk and identify who benefits from corticosteroids. A score ≥9 indicates poor prognosis and, when paired with MDF ≥32, predicts survival benefit from prednisolone (28‑day mortality 52% untreated vs 78% treated; p=0.002) 1 [Level II evidence]. A score <9 indicates low short‑term mortality with no steroid benefit 2 [Level I evidence].
Insights e Precauções
Identifies severe cases (≥9) with high short‑term mortality and likely corticosteroid benefit, but accuracy is modest and geography‑limited. Validation shows improved 28‑/84‑day prognostic performance over mDF (AUC ~0.81 vs 0.49) 1 [Level II evidence], and steroid benefit only when ≥9 (28‑day survival 78% vs 52%; p=0.002) 2 [Level II evidence]. Not validated outside the UK and inferior to MELD in global cohorts. Use cautiously and always alongside clinical judgment.